The ITA confirms that weightlifter Dilnoza Fayzullaeva has agreed¹ to the consequences imposed for her anti-doping rule violation (ADRV).
Dilnoza Fayzullaeva provided a sample collected under the testing authority of the IWF during an unannounced in-competition doping control performed on 25 May 2024 during the IWF World Youth Championships, Lima, Peru, which yielded an adverse analytical finding² (AAF) for furosemide.
Furosemide is prohibited under the WADA Prohibited List as S5 Diuretics and Masking Agents. It is prohibited at all times (in- and out-of-competition) and is classified as a specified substance. Furosemide can be used by athletes to excrete water for rapid weight loss.
The athlete did not challenge the ADRV and agreed with the consequences proposed by the ITA. Accordingly, the case was resolved via an acceptance of consequences.
The athlete’s period of ineligibility is from 8 August 2024 until 7 August 2026. In addition, all the athlete’s individual competitive results as from 25 May 2024 until the start of the period of ineligibility are disqualified.
The decision may be challenged before the appeals division of the Court of Arbitration for Sport by the parties with a right of appeal in accordance with article 13.2.3 of the IWF anti-doping rules.
The ITA will not comment further on these cases.